The conference will have discussions on latest developments in drug anti-counterfeiting
Messed Frankfurt Trade Fairs India, with its commitment to fight the menace of counterfeit and spurious drugs, will organise the second edition of Pharmasafe India in Mumbai from September
High level representation from various government and regulatory stake holders are expected to transform the discussion-points into action-points. Speakers including Dr Shailesh Ayyangar, Managing Director, India & Vice President, South Asia, Sanofi & President, Organization of Pharmaceutical Producers of India; Dr Rao VSV Vadlamudi, President, Indian Pharmaceutical Association; Samson Chiu, Director, Asia Pacific Region, Pharmaceutical Security Institute; Edmond d’Arvieu, Vice President – Corporate Security, Sanofi, Bejon Misra, Founder, Partnership for Safe Medicines India and Prashant Tandon, Founder, 1 mg, will give insights into the latest trends in anti-counterfeit technologies, discussions on counterfeiting in parallel trade, as well as case studies on a global and domestic level.
Apart from an eminent speakers, the conference has also drawn support from both pharmaceutical companies and industry associations such as OPPI, IDMA, IPA, IPEC, ASPA, Sanofi and HP. The scale and scope of the event will further be enhanced by a line-up of expert speakers taking up the most pertinent and relevant topics to draw attention to the source of counterfeit medicines and effective initiatives, regulations, and policies of the $4.25 billion (Rs 65675.5 crores) fake drugs market, in order to safeguard public health.
EP News Bureau